Inhibition of JAK/STAT3 signaling suppresses self-renewal of breast cancer stem cells (BCSCs) and downregulates key lipid metabolic genes such as carnitine palmitoyltransferase 1B (CPT1B), which encodes a rate-limiting enzyme in fatty acid β-oxidation (FAO). The gene discussed is STAT3; the disease is breast cancer.